Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 31S-34S , May 1999

The impact of generic drugs on the cost of transplantation medical care

  • A.J Olyaei

      Affiliations

    • Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland, Oregon, USA
  • ,
  • A.M deMattos

      Affiliations

    • Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland, Oregon, USA
  • ,
  • W.M Bennett

      Affiliations

    • Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland, Oregon, USA
    • Corresponding Author InformationAddress reprint requests to William M. Bennett, MD, Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, 3314 SW US Veterans Hospital Rd, Portland, OR 97201

References 

  1. Evans RW, Kitzmann DJ. Surg Clin North Am. 1998;78:149
  2. Buxton MJ. Transplant Proc. 1997;29:2723
  3. National Prescription Audit. Plymouth Meeting, PA 1996
  4. Meredith PA. Drug Safety. 1996;15:233
  5. Benet LZ, Goyan JE. Pharmacotherapy. 1995;15:433
  6. Nightingale SL. JAMA. 1998;279:645
  7. Banahan BF, Kolassa EM. Arch Intern Med. 1997;157:2080
  8. Anonymous . Am J Health Sys Pharm. 1997;54:2799
  9. Anonymous . Am J Health Sys Pharm. 1997;54:1630
  10. de Mattos AM, Olyaei AJ, Bennett WM. Am J Kidney Dis. 1996;28:631
  11. Olyaei AJ, de Mattos AM, Bennett WM. Drug Safety. 1997;16:366
  12. Johnson KT. Drug Util Prac. 1997;5:1
  13. Sanchez LA. Pharmacoeconomic. 1994;5:367
  14. Mcghan BF, Briesacher BA. Pharmacoeconomic. 1994;6:412
  15. Gouveia WA. J Health Sys Pharm. 1995;52:S1
  16. Kaye TB. Am J Health Sys Pharm. 1996;53:1536
  17. Pink Sheet 60:8, 1998

PII: S0041-1345(99)00111-6

Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 31S-34S , May 1999